Archives of Clinical Infectious Diseases

Published by: Kowsar

Cerebellar Mucormycosis in a Young Man: A Case Report

Hossein Mashhadinezhad 1 and Mohammad Ali Abouei Mehrizi 2 , *
Authors Information
1 Professor of Neurosurgery, Department of Neurosurgery, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
2 Resident of Neurosurgery, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Article information
  • Archives of Clinical Infectious Diseases: August 2018, 13 (4); e62962
  • Published Online: July 29, 2017
  • Article Type: Case Report
  • Received: November 1, 2016
  • Revised: February 13, 2017
  • Accepted: March 14, 2017
  • DOI: 10.5812/archcid.62962

To Cite: Mashhadinezhad H, Abouei Mehrizi M A. Cerebellar Mucormycosis in a Young Man: A Case Report, Arch Clin Infect Dis. 2018 ; 13(4):e62962. doi: 10.5812/archcid.62962.

Abstract
Copyright © 2017, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
References
  • 1. Air EL, Vagal AA, Kendler A, McPherson CM. Isolated cerebellar mucormycosis, slowly progressive over 1 year in an immunocompetent patient. Surg Neurol Int. 2010;1:81. doi: 10.4103/2152-7806.73800. [PubMed: 21206542].
  • 2. Bhadada S, Bhansali A, Reddy KS, Bhat RV, Khandelwal N, Gupta AK. Rhino-orbital-cerebral mucormycosis in type 1 diabetes mellitus. Indian J Pediatr. 2005;72(8):671-4. doi: 10.1007/BF02724075. [PubMed: 16131772].
  • 3. Verma A, Brozman B, Petito CK. Isolated cerebral mucormycosis: report of a case and review of the literature. J Neurol Sci. 2006;240(1-2):65-9. doi: 10.1016/j.jns.2005.09.010. [PubMed: 16269155].
  • 4. Cook BA, White CB, Blaney SM, Bass JW. Survival after isolated cerebral mucormycosis. Am J Pediatr Hematol Oncol. 1989;11(3):330-3. [PubMed: 2782563].
  • 5. Eucker J, Sezer O, Lehmann R, Weber JR, Graf B, Denkert C, et al. Disseminated mucormycosis caused by Absidia corymbifera leading to cerebral vasculitis. Infection. 2000;28(4):246-50. doi: 10.1007/s150100070047. [PubMed: 10961535].
  • 6. Grannan BL, Yanamadala V, Venteicher AS, Walcott BP, Barr JC. Use of external ventriculostomy and intrathecal anti-fungal treatment in cerebral mucormycotic abscess. J Clin Neurosci. 2014;21(10):1819-21. doi: 10.1016/j.jocn.2014.01.008. [PubMed: 24852901].
  • 7. Hopkins RJ, Rothman M, Fiore A, Goldblum SE. Cerebral mucormycosis associated with intravenous drug use: three case reports and review. Clin Infect Dis. 1994;19(6):1133-7. doi: 10.1093/clinids/19.6.1133. [PubMed: 7888545].
  • 8. Terk MR, Underwood DJ, Zee CS, Colletti PM. MR imaging in rhinocerebral and intracranial mucormycosis with CT and pathologic correlation. Magn Reson Imaging. 1992;10(1):81-7. doi: 10.1016/0730-725X(92)90376-B. [PubMed: 1545686].
  • 9. Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, et al. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007). Clin Infect Dis. 2012;54 Suppl 1:S35-43. doi: 10.1093/cid/cir880. [PubMed: 22247443].
  • 10. Daly AL, Velazquez LA, Bradley SF, Kauffman CA. Mucormycosis: association with deferoxamine therapy. Am J Med. 1989;87(4):468-71. doi: 10.1016/S0002-9343(89)80836-8. [PubMed: 2679077].
  • 11. Artis WM, Patrusky E, Rastinejad F, Duncan RJ. Fungistatic mechanism of human transferrin for Rhizopus oryzae and Trichophyton mentagrophytes: alternative to simple iron deprivation. Infect Immun. 1983;41(3):1269-78. [PubMed: 6885162].
  • 12. Holzberg M, Artis WM. Hydroxamate siderophore production by opportunistic and systemic fungal pathogens. Infect Immun. 1983;40(3):1134-9. [PubMed: 6221998].
  • 13. Spellberg B, Ibrahim A, Roilides E, Lewis RE, Lortholary O, Petrikkos G, et al. Combination therapy for mucormycosis: why, what, and how? Clin Infect Dis. 2012;54 Suppl 1:S73-8. doi: 10.1093/cid/cir885. [PubMed: 22247449].
  • 14. Spellberg B, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris MI, Perfect JR, et al. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother. 2012;67(3):715-22. doi: 10.1093/jac/dkr375. [PubMed: 21937481].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments